EPH3 Effectiveness of Additional Risk Minimization Measures When Using Baricitinib (RISK-BARI): Preliminary Analysis
Abstract
Authors
A.M. Silva A Moreira L Jacinto A Gamboa JP Fernandes M Silva M Melo
A.M. Silva A Moreira L Jacinto A Gamboa JP Fernandes M Silva M Melo
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now